Skip to main content
. 2022 Mar 8;13:827981. doi: 10.3389/fpsyt.2022.827981

Figure 4.

Figure 4

ARG S1PR1 intensity expression (fmol/mg) triplicate measures (M1, M2, and M3) in the DLPFC from normal controls, schizophrenia Type 1, and schizophrenia Type 2.